Tamara Lützenburg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tamara Lützenburg has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Haseloer
University of Cologne Department of Chemistry Institute for Inorganic Chemistry Greinstrasse 4–6 50939 Cologne Germany
1 shared publication - Axel Klein
Faculty for Mathematics and Natural Sciences Department of Chemistry and Biochemistry Institute for Inorganic and Materials Chemistry University of Cologne Köln Germany
1 shared publication - Ines Neundorf
University of Cologne, Germany
1 shared publication - Joss Pepe Strache
Department of Chemistry University of Cologne Greinstrasse 4 50939 Köln Germany
1 shared publication - Jörg-Martin Neudörfl
Institute for Light and Matter Department of Chemistry and Biochemistry University of Cologne Cologne Germany
1 shared publication
Latest Publications
- Open Access
- 10 September 2020
- Published by Wiley in ChemBioChem
- Vol. 22 (4) , 694-704
Building up PtII−Thiosemicarbazone−Lysine−sC18 Conjugates
Three chiral tridentate N^N^S coordinating pyridine‐carbaldehyde (S)‐N4‐(α‐methylbenzyl)thiosemicarbazones (HTSCmB) were synthesised along with lysine‐modified derivatives. One of them was selected and covalently conjugated to the cell‐penetrating peptide sC18 by solid‐phase peptide synthesis. The HTSCmB model ligands, the HTSCLp derivatives and the peptide conjugate rapidly and quantitatively form very stable PtII chlorido complexes [Pt(TSC)Cl] when treated with K2PtCl4 in solution. The Pt(CN) derivatives were obtained from one TSCmB model complex and the peptide conjugate complex through Cl−→CN− exchange. Ligands and complexes were characterised by NMR, IR spectroscopy, HR‐ESI‐MS and single‐crystal XRD. Intriguingly, no decrease in cell viability was observed when testing the biological activity of the lysine‐tagged HdpyTSCLp, its sC18 conjugate HdpyTSCL‐sC18 or the PtCl and Pt(CN) conjugate complexes in three different cell lines. Thus, given the facile and effective preparation of such Pt‐TSC‐peptide conjugates, these systems might pave the way for future use in late‐stage labelling with Pt radionuclides and application in nuclear medicine.
- 10 September 2020
- Published by Wiley in ChemBioChem
- Vol. 22 (4) , 694-704
Open AccessBuilding up PtII−Thiosemicarbazone−Lysine−sC18 Conjugates
Three chiral tridentate N^N^S coordinating pyridine‐carbaldehyde (S)‐N4‐(α‐methylbenzyl)thiosemicarbazones (HTSCmB) were synthesised along with lysine‐modified derivatives. One of them was selected and covalently conjugated to the cell‐penetrating peptide sC18 by solid‐phase peptide synthesis. The HTSCmB model ligands, the HTSCLp derivatives and the peptide conjugate rapidly and quantitatively form very stable PtII chlorido complexes [Pt(TSC)Cl] when treated with K2PtCl4 in solution. The Pt(CN) derivatives were obtained from one TSCmB model complex and the peptide conjugate complex through Cl−→CN− exchange. Ligands and complexes were characterised by NMR, IR spectroscopy, HR‐ESI‐MS and single‐crystal XRD. Intriguingly, no decrease in cell viability was observed when testing the biological activity of the lysine‐tagged HdpyTSCLp, its sC18 conjugate HdpyTSCL‐sC18 or the PtCl and Pt(CN) conjugate complexes in three different cell lines. Thus, given the facile and effective preparation of such Pt‐TSC‐peptide conjugates, these systems might pave the way for future use in late‐stage labelling with Pt radionuclides and application in nuclear medicine.